Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharma - API
  4. /Gujarat Themis Biosyn Ltd
MomentumDeep Value

Gujarat Themis Biosyn Ltd: Stock Analysis & Fundamentals

Updated this week

Gujarat Themis Biosyn Ltd (Pharma - API) — fundamental analysis, earnings data, and key metrics. PE: 57.4. ROE: 21.7%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

📊Debt increased 137% YoY — leverage rising
🌐FII stake increased 1.5% this quarter

Key Numbers

Current Price
₹252
Dividend Yield
0.27%
Market Cap
2.7K Cr
Valuation
N/A

Other Top Pharma - API Stocks Beating Nifty 500

Senores Pharmaceuticals Ltd
Average
+8.4%
Ind-Swift Laboratories Ltd
Average • 10w streak
+62.6%
Fermenta Biotech Ltd
Average
+8.3%
← Back to Pharma - APIDashboard

Frequently Asked Questions: Gujarat Themis Biosyn Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Gujarat Themis Biosyn Ltd's latest quarterly results?

Gujarat Themis Biosyn Ltd's latest quarterly results (Dec 2025) show

  • PAT Growth YoY: -7.7%
  • Revenue Growth YoY: +7.5%
  • Operating Margin: 49.0%

What is Gujarat Themis Biosyn Ltd's current PE ratio?

Gujarat Themis Biosyn Ltd's current PE ratio is 57.4x.

  • Current PE: 57.4x
  • Market Cap: 2.7K Cr
  • Dividend Yield: 0.27%

What is Gujarat Themis Biosyn Ltd's price-to-book ratio?

Gujarat Themis Biosyn Ltd's price-to-book ratio is 10.4x.

  • Price-to-Book (P/B): 10.4x
  • Book Value per Share: ₹24
  • Current Price: ₹252

Is Gujarat Themis Biosyn Ltd a fundamentally strong company?

Gujarat Themis Biosyn Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 27.0%

Is Gujarat Themis Biosyn Ltd debt free?

Gujarat Themis Biosyn Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹71 Cr

What is Gujarat Themis Biosyn Ltd's return on equity (ROE) and ROCE?

Gujarat Themis Biosyn Ltd's return ratios over recent years

  • FY2023: ROCE 61.0%
  • FY2024: ROCE 45.0%
  • FY2025: ROCE 27.0%

Is Gujarat Themis Biosyn Ltd's cash flow positive?

Gujarat Themis Biosyn Ltd's operating cash flow is positive (FY2025).

  • Cash from Operations (CFO): ₹91 Cr
  • Free Cash Flow (FCF): ₹-21 Cr
  • CFO/PAT Ratio: 186% (strong cash conversion)

What is Gujarat Themis Biosyn Ltd's dividend yield?

Gujarat Themis Biosyn Ltd's current dividend yield is 0.27%.

  • Dividend Yield: 0.27%
  • Current Price: ₹252

Who holds Gujarat Themis Biosyn Ltd shares — promoters, FII, DII?

Gujarat Themis Biosyn Ltd's shareholding pattern (Dec 2025)

  • Promoters: 70.9%
  • FII (Foreign): 2.0%
  • DII (Domestic): 1.2%
  • Public: 26.0%

Is promoter holding increasing or decreasing in Gujarat Themis Biosyn Ltd?

Gujarat Themis Biosyn Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 70.9% (Dec 2025)
  • Previous Quarter: 70.9% (Sep 2025)
  • Change: 0.00% (stable)

Is Gujarat Themis Biosyn Ltd a new momentum entry or an established outperformer?

Gujarat Themis Biosyn Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Gujarat Themis Biosyn Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Gujarat Themis Biosyn Ltd may be worth studying

  • Cash flow is positive — CFO ₹91 Cr

What is the investment thesis for Gujarat Themis Biosyn Ltd?

Gujarat Themis Biosyn Ltd investment thesis summary:

What is the future outlook for Gujarat Themis Biosyn Ltd?

Gujarat Themis Biosyn Ltd's forward outlook based on current data signals

  • Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.